Pharmaceutical Supply – Tamsulosin Hydrochloride Capsules
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract pertains to the supply and delivery of one bulk unit of Tamsulosin Hydrochloride Capsules, designated for federal medical distribution under the jurisdiction of the Department of Defense. The pharmaceutical product must meet all applicable FDA standards as well as stringent Department of Defense requirements to ensure safety, efficacy, and regulatory compliance throughout the supply chain. This subcontract, issued under NAICS code 325412 for pharmaceutical preparation manufacturing, is managed by the Defense Logistics Agency and aligns with federal procurement protocols for medical procurement. The award is tied to contract reference SPE2DX25D8022 with delivery identifier SPE2D926F7412, and while specific delivery locations are not detailed, the product is intended for use within the federal healthcare system serving military and veteran populations. The solicitation was posted on July 16, 2026, and the contract is structured to facilitate bulk procurement with strict adherence to quality and logistical standards required by federal medical authorities.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
This scope was carved out of SPE2D926F7412.
The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.
TAMSULOSIN HYDROCHLORIDE CAPSULES
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
